Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells
Jinxiang Wang, Leli Zeng, Nisha Wu, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100985-100985
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions
Guang Lei, Li Zhuang, Boyi Gan
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 513-534
Open Access | Times Cited: 106
Ferroptosis: principles and significance in health and disease
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 45
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
Yutian Zou, Anli Yang, Bo Chen, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101126-101126
Closed Access | Times Cited: 21
Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics
Gang Che, Jie Yin, Wankun Wang, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101080-101080
Closed Access | Times Cited: 16
VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis
Juan Yang, Lu Xiao, Jinglan Hao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
PHGDH: a novel therapeutic target in cancer
Chae Min Lee, Yeseong Hwang, Minki Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 7, pp. 1513-1522
Open Access | Times Cited: 9
Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer
Sheng Ma, Zixian Wang, Zezhong Xiong, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
New 2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-one derivatives as antimicrobial and anti-cancer agents: Synthesis, in-vitro and SAR studies
Farid M. Sroor, Abdelmageed M. Othman, Khaled Mahmoud, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136516-136516
Closed Access | Times Cited: 14
Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer
Mengjun Huang, Qiliang Teng, Fei Cao, et al.
Biomaterials Science (2024) Vol. 12, Iss. 7, pp. 1617-1629
Closed Access | Times Cited: 5
Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction
Xue Li, Ying Cheng, Zhifu Yang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers
Pham Hong Anh Cao, Abishai Dominic, Fabiola Ester Lujan, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 10, pp. 615-637
Closed Access | Times Cited: 5
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Interaction of PHGDH with IGF2BP1 facilitates m6A-dependent stabilization of TCF7L2 mRNA to confer multidrug resistance in gastric cancer
Shuyi Chen, Tingyu Li, Dan Liu, et al.
Oncogene (2025)
Open Access
FOXC1-mediated serine metabolism reprogramming enhances colorectal cancer growth and 5-FU resistance under serine restriction
Zhukai Chen, Jiacheng Xu, Kang Fang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Cellular Signaling of Amino Acid Metabolism in Prostate Cancer
Ping Yao, Shiqi Cao, Zhiguang Zhu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 776-776
Open Access
Inhibition of Galectin-1 and Androgen Receptor Axis Enhances Enzalutamide Treatment in Enzalutamide Resistant Prostate Cancer
Hsiao-Chi Wang, Allen C. Gao, Roger Xia, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 351-351
Open Access
Transcriptional Regulation of NUPR1 by MYH11 Activates PI3 K/AKT and Promotes Bladder Cancer Progression Through Ferroptosis and M2 Polarization of Macrophages
Lifeng Zhang, Li Zhang, Zebin Shi, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
YY2 mediates transcriptional repression of PHGDH and expedites oxidative stress in retinal pigment epithelial cells in diabetic retinopathy
Xiang Lei, Xiu Jun Wang, X. Zhang
Journal of Diabetes Investigation (2025)
Open Access
Generation of Myeloid‐Specific Bmal1 Knockout Mice and Identification of Bmal1‐Regulated Ferroptosis in Macrophages
Qing Chen, Wenyi Wang, Weijun Fang, et al.
genesis (2025) Vol. 63, Iss. 2
Closed Access
Integrated bioinformatics analysis reveals that OPRK1 inhibits ferroptosis and induces enzalutamide resistance in prostate cancer
Liangrong Zhang, Yanqin Liu, Xiaodong Wen, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Magnetically actuated sonodynamic nanorobot collectives for potentiated ovarian cancer therapy
Yixuan Zhou, Ziqi Cao, Lixian Jiang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 3
PPARγ Antagonists Exhibit Antitumor Effects by Regulating Ferroptosis and Disulfidptosis
Shiyu Zhang, Ying Wang, Junjie Gu, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 596-596
Open Access | Times Cited: 3
Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant
Wenshu Li, Long‐Yuan Li, Huan Yang, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 7
Open Access | Times Cited: 3
HJURP inhibits sensitivity to ferroptosis inducers in prostate cancer cells by enhancing the peroxidase activity of PRDX1
Wenjie Lai, Weian Zhu, Jianjie Wu, et al.
Redox Biology (2024) Vol. 77, pp. 103392-103392
Open Access | Times Cited: 3
Identification of cell differentiation trajectory-related gene signature to reveal the prognostic significance and immune landscape in prostate cancer based on multiomics analysis
Liangxue Sun, Zhouting Tuo, Xin Chen, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27628-e27628
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top